Meyka Pro banner
Qilian International Holding Group Limited

Qilian International Holding Group Limited (QLI) Stock Overview

Explore Qilian International Holding Group Limited’s financial performance, market position, analyst ratings, and future outlook.

QLINASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$5.41
$0.20(3.57%)
U.S. Market is Open · 13:55

Qilian International Holding Group Limited (QLI)

Meyka AI Score

Z

Key Financials

Market Cap38.7M
P/E Ratio-24.59
EPS (TTM)$-1.10
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

QLI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Qilian International Holding Group Limited (NASDAQ: QLI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Qilian International Holding Group Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of QLI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Qilian International Holding Group Limited's NASDAQ-traded stock include a P/E ratio of -24.59 and a market capitalization of 38.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of QLI on the NASDAQ.

Price Performance (NASDAQ: QLI)

1-Day Change
N/A
5-Day Change
-24.76%
1-Month Change
-6.08%
3-Month Change
49.04%
6-Month Change
89.82%
Year-to-Date (YTD) Change
68.54%
1-Year Change
35.93%
3-Year Change
-73.67%
5-Year Change
-89.18%
All-Time (Max) Change
-89.18%

Contact Information

86 02 8647 75180
Jiuquan Eco & Tech Dev Zn, Jiuquan, NaN, 735000

Company Facts

2,980 Employees
IPO DateJan 12, 2021
CountryCN

Frequently Asked Questions